	Collagen and CXCL10 expression as key components of the structural and inflammatory dimensions of the tumor microenvironment in breast cancer subtypes. Acta Histochem Nakano LKM, Moreira TB, Pereira RA, Mesquita FAS, Teixeira-Carvalho A, Salles PGO, Portella MAM, Amorim IFG, Braga LDC. PMID: 43033750 [PubMed - as supplied by publisher]
	Pregnancy after breast cancer and risk of recurrence. A risk-set-matched cohort study with a time-dependent analysis. Cancer Epidemiol Bonyadi M, Hosseinpour Z, Akbari A, Akbari ME. PMID: 43033674 [PubMed - as supplied by publisher]
	Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE). Breast Ozaki Y, Taniguchi E, Nozawa K, Niwa Y, Hara F, Nonogaki K, Kuno M, Aoyama Y, Inagaki L, Masuda J, Nishimura M, Kurata M, Hosonaga M, Fukada I, Kimura Y, Maeda T, Yoshida K, Yamashita N, Kobayashi T, Takano T, Ueno T. PMID: 43033562 [PubMed - as supplied by publisher]
	Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer. Int J Clin Oncol Kawaguchi-Sakita N, Naito Y, Ishida T, Nakayama T, Yamamoto Y, Masuda N, Matsumoto K, Kogawa T, Sudo K, Shimomura A, Lai C, Shao J, Iwahori Y, Gary D, Huynh D, Iwata H. PMID: 43033364 [PubMed - as supplied by publisher]
	Screening for rehabilitation needs in newly diagnosed breast cancer patients: exploring psychometric properties of the National Comprehensive Cancer Network(Â®) (NCCN(Â®)) Distress Thermometer and Problem List. J Patient Rep Outcomes Velickovic K, Bendahl PO, Olsson Möller U, Rydén L, Malmström M. PMID: 43033328 [PubMed - indexed for MEDLINE]
	Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors. Breast Cancer Res Treat Petrelli F, Ghidini A, Parati MC, Ghilardi M, Borgonovo K, Dottorini L. PMID: 43033310 [PubMed - indexed for MEDLINE]
	Association between screen-detected health-related social needs and nonadherence to endocrine therapy in patients with nonmetastatic breast cancer: an observational study. Breast Cancer Res Treat Liyanage-Don N, DeStephano D, Sathe C, Lee S, Beauchemin M, Accordino M, Hershman D, Kronish IM. PMID: 43033306 [PubMed - indexed for MEDLINE]
	Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis. Breast Cancer Res Treat Wu Y, Kong L, Oghenefejiro EE, Cao X, Wang D, Tao C, Wang X, Qin R, Ji Y, Yin L. PMID: 43033282 [PubMed - indexed for MEDLINE]
	Changes in functional capacity, flexibility and depressive symptoms in women with breast cancer submitted to adjuvant radiotherapy: randomized controlled clinical trial with mat pilates. Support Care Cancer Torres DM, de Menezes Fireman K, Fabro EAN, Thuler LCS, Bergmann A, da Silva Santos S. PMID: 43033270 [PubMed - indexed for MEDLINE]
	Cardiac substructure dose in thoracic VMAT without explicit constraints: FMO versus SPO on uRT-TPOIS with cross-platform reference to eclipse PO. J Appl Clin Med Phys Wu C, Cao Z, Duan T, Han L, Wang B, Lei W. PMID: 43033214 [PubMed - indexed for MEDLINE]
	Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Oncology Komatsu T, Osawa H, Cronin K, Okazawa K, Suzuki T, Tiersten A. PMID: 43033143 [PubMed - as supplied by publisher]
	CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer. ACS Sens Wu S, Xu J, Sun Y, Zeng T, Li Z, Zhou T, Deng Y, Ye C, Li G, Yin Y. PMID: 43033087 [PubMed - as supplied by publisher]
	Cross-ancestry proteome-wide mendelian randomization of plasma proteins and breast cancer susceptibility. J Natl Cancer Inst Wu X, Godbole D, Williams J, Sharma J, Choi J, Liu Z, Kraft P, Zhang H. PMID: 43033043 [PubMed - as supplied by publisher]
	Pre-Radiotherapy Risk Prediction of Grade â‰¥2 Radiotherapy-Induced Lymphopenia in Breast Cancer: A Single-Center Interpretable Machine Learning Study. Int J Gen Med Ding L, Qiu H, Wang M, Lu Y, Huang T, Wang Y, Shi Q, Shen K. PMID: 43032615 [PubMed]
	The SLC7A11-ferroptosis axis in BRCA1-mutant breast cancer: current mechanistic evidence, potential therapeutic vulnerabilities, and translational perspectives. Front Oncol Yang Y, Li Y, Hao X, Yan W, Ma X. PMID: 43032317 [PubMed]
	Is polyendocrine metabolic ovarian syndrome a legacy of excessive gestational weight gain? A review of developmental and transgenerational programming. Front Endocrinol (Lausanne) Ge Z, Wang J, Zhang C. PMID: 43032074 [PubMed - indexed for MEDLINE]
	"Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer. Med Sci Educ Slaybe A, Barengo NC, Runowicz CD. PMID: 43032027 [PubMed]
	A Pilot Study to Assess the Efficacy and Safety of Capecitabine-Based Chemoradiotherapy for Cisplatin-Ineligible Patients with Squamous Cell Carcinoma of the Uterine Cervix. J Obstet Gynaecol India Sundararajan D, Vengada Krishnan, Rajeev G, Jayapaul VC, Jayachandran PK, Radhakrishnan V, Dhanushkodi M, Madhavan R. PMID: 43032021 [PubMed]
	Development of evidence-based nursing recommendations for hand-foot syndrome in breast cancer chemotherapy patients. Front Oncol Huang L, Lu H, Zhou Y, Yuan J, Lan D, Xu Y. PMID: 43031934 [PubMed]
	Estrogenic, cytotoxic, proliferative effects of mycotoxins in human breast cancer cell line models: a systematic review. Front Public Health Sasidharan S, Naina P, Jyoti D, Arora T, Burman A, Bansal S, Gowardhan S, Mishra A, Chandra N. PMID: 43031852 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 338133

Page 1 of 16907



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy